Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells
Oncogene - United Kingdom
doi 10.1038/sj.onc.1208774
Full Text
Open PDFAbstract
Available in full text
Date
August 8, 2005
Authors
Publisher
Springer Science and Business Media LLC